Clinical significance of activity of ALT enzyme in patients with hepatitis C virus
- PMID: 17907292
- PMCID: PMC4171283
- DOI: 10.3748/wjg.v13.i41.5481
Clinical significance of activity of ALT enzyme in patients with hepatitis C virus
Abstract
Aim: To investigate serum alanine aminotransferase (ALT) levels in relation to the clinical, biochemical, ultrasonographic and histological characteristics of patients with hepatitis C virus.
Methods: Duration of disease, HCV-RNA, liver steatosis, and the hepatitis activity index (HAI) were correlated with serum ALT in 36 patients with HCV. ALT values were also investigated in 16 control subjects without any liver diseases.
Results: In bivariate analyses, ALT levels correlated with duration of HCV infection (P < 0.01), HCV-RNA (P < 0.05), and the HAI (P < 0.01). Among the components of the HAI, ALT concentrations were significantly associated with periportal bridging/necrosis (P < 0.01) and fibrosis (P < 0.05). In multivariate analysis, periportal bridging/necrosis (beta = 0.508; P < 0.01), duration of HCV infection (beta = 0.413; P < 0.01), and HCV-RNA (beta = 0.253; P < 0.05) were independently associated with ALT activity. The normal ALT activity for men and women was < 23 IU/L and < 22 IU/L, respectively.
Conclusion: In patients with HCV, alterations in the liver tissue as reflected by ALT elevation are mainly associated with periportal bridging/necrosis, viral load and duration of disease. A cut-off value < 23 IU/L distinguished with high diagnostic accuracy healthy controls from patients with HCV.
Figures





Similar articles
-
Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.Am J Gastroenterol. 1996 Aug;91(8):1516-22. Am J Gastroenterol. 1996. PMID: 8759653
-
AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.Dig Dis Sci. 1998 Sep;43(9):2156-9. doi: 10.1023/a:1018888021118. Dig Dis Sci. 1998. PMID: 9753286
-
Incidentally detected asymptomatic hepatitis C virus infection with significant fibrosis: Possible impacts on management.Indian J Pathol Microbiol. 2018 Jul-Sep;61(3):345-349. doi: 10.4103/IJPM.IJPM_240_17. Indian J Pathol Microbiol. 2018. PMID: 30004052
-
Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan.J Gastroenterol Hepatol. 1998 Jul;13(7):685-90. doi: 10.1111/j.1440-1746.1998.tb00714.x. J Gastroenterol Hepatol. 1998. PMID: 9715418
-
Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection.Curr Pharm Des. 2008;14(17):1661-5. doi: 10.2174/138161208784746789. Curr Pharm Des. 2008. PMID: 18673189 Review.
Cited by
-
Molecular serum markers of liver fibrosis.Biomark Insights. 2012;7:105-17. doi: 10.4137/BMI.S10009. Epub 2012 Jul 23. Biomark Insights. 2012. PMID: 22872786 Free PMC article.
-
Self-awareness of hepatitis C infection in the United States: A cross-sectional study based on the National Health Nutrition and Examination Survey.PLoS One. 2023 Oct 24;18(10):e0293315. doi: 10.1371/journal.pone.0293315. eCollection 2023. PLoS One. 2023. PMID: 37874815 Free PMC article.
-
Routine blood tests to predict liver fibrosis in chronic hepatitis C.World J Gastroenterol. 2012 Feb 28;18(8):746-53. doi: 10.3748/wjg.v18.i8.746. World J Gastroenterol. 2012. PMID: 22371634 Free PMC article.
-
Iron Pathways and Iron Chelation Approaches in Viral, Microbial, and Fungal Infections.Pharmaceuticals (Basel). 2020 Sep 25;13(10):275. doi: 10.3390/ph13100275. Pharmaceuticals (Basel). 2020. PMID: 32992923 Free PMC article. Review.
-
Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older.BMC Gastroenterol. 2022 Apr 28;22(1):210. doi: 10.1186/s12876-022-02284-z. BMC Gastroenterol. 2022. PMID: 35484503 Free PMC article.
References
-
- Hughes CA, Shafran SD. Chronic hepatitis C virus management: 2000-2005 update. Ann Pharmacother. 2006;40:74–82. - PubMed
-
- Sievert W. Management issues in chronic viral hepatitis: hepatitis C. J Gastroenterol Hepatol. 2002;17:415–422. - PubMed
-
- Teoh NC, Farrell GC. Management of chronic hepatitis C virus infection: a new era of disease control. Intern Med J. 2004;34:324–337. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical